venlafaxine has been researched along with desvenlafaxine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andree, T; Bicksler, J; Butch, J; Fletcher, H; Husbands, GE; James, MN; Moyer, JA; Muth, EA; Stack, G; Yardley, JP | 1 |
| Dormann, SM; Haefeli, WE; Kerpen, CJ; Ketabi-Kiyanvash, N; Martin-Facklam, M; Weiss, J | 1 |
| Badescu, VO; de Frutos, O; de la Puente, ML; Ding, C; Dreyfus, N; Filla, SA; Fynboe, K; Gernert, DL; Heinz, BA; Hemrick-Luecke, SK; Iyengar, S; Johansson, AM; Johnson, KW; Johnson, MP; Joshi, E; López, P; Love, PL; Martin, LJ; Masquelin, T; McCoy, MJ; Mendiola, J; Morrow, D; Muhlhauser, M; Myers, JK; Pascual, G; Perun, TJ; Pfeifer, LA; Phebus, LA; Richards, SJ; Rincón, JA; Seest, EP; Shah, J; Shaojuan, J; Simmons, RM; Stephenson, GA; Thomas, CE; Thompson, LK; Tromiczak, EG; Walter, MW; Weber, WW; Zarrinmayeh, H | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Subbaiah, MAM | 1 |
| Choi, Y; Raymer, BK | 1 |
3 review(s) available for venlafaxine and desvenlafaxine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Drug Design; Humans; Selective Serotonin Reuptake Inhibitors | 2018 |
Sleep modulating agents.
Topics: Animals; Humans; Sleep; Sleep Aids, Pharmaceutical; Sleep Wake Disorders; Wakefulness-Promoting Agents | 2019 |
3 other study(ies) available for venlafaxine and desvenlafaxine
| Article | Year |
|---|---|
2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Binding, Competitive; Biological Assay; Biological Transport; Brain; Chemical Phenomena; Chemistry, Physical; Crystallography; Hypothermia; Imipramine; In Vitro Techniques; Models, Molecular; Neurotransmitter Agents; Norepinephrine; Phenethylamines; Rats; Receptors, Adrenergic, beta; Receptors, Serotonin; Reserpine; Serotonin; Structure-Activity Relationship; X-Ray Diffraction | 1990 |
Inhibition of P-glycoprotein by newer antidepressants.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Endothelium, Vascular; Humans; Reproducibility of Results; Swine; Transfection | 2003 |
Discovery of a potent, dual serotonin and norepinephrine reuptake inhibitor.
Topics: | 2013 |